Abstract
Two groups of six healthy male volunteers were studied to assess the possibility of an interaction between dextropropoxyphene and theophylline or tolbutamide using a randomised, crossover design. Subjects received theophylline 125 mg 8 hourly or tolbutamide 500 mg i.v. with and without dextropropoxyphene hydrochloride 65 mg 8 hourly. Theophylline 8‐hydroxylation was reduced by a mean of 17% but there were no changes in theophylline 1‐demethylation, theophylline 3‐ demethylation or tolbutamide hydroxylation. 1987 The British Pharmacological Society
| Original language | English |
|---|---|
| Pages (from-to) | 772-775 |
| Number of pages | 4 |
| Journal | British Journal of Clinical Pharmacology |
| Volume | 23 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - Jun 1987 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Specificity of the inhibitory effect of dextropropoxyphene on oxidative drug metabolism in man: effects on theophylline and tolbutamide disposition.'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver